press
Published on: December 11, 2018 | BRANFORD, CT.

InveniAI Enters Strategic Artificial Intelligence Collaboration with Kyowa Hakko Kirin

Focus on leveraging the power of AI to expand the therapeutic index of existing portfolio
BRANFORD, CT December 11, 2018, InveniAI® Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to Read More

press
Published on: October 17, 2018 | BRANFORD, CT.

InveniAI®’s Innovation Monitoring Platform, AlphaMeld™, Witnesses Rapid Uptake in BioPharma and Adjacencies

InveniAI®’s Innovation Monitoring Platform, AlphaMeld™, Witnesses Rapid Uptake in BioPharma and Adjacencies
Platform built to detect the earliest signs of innovation in real-time and across industries
Branford, CT – October 17, 2018 InveniAI® Corporation, a global leader in pioneering the Read More

press
Published on: May 22, 2017 | BRANFORD, CT.

Companies are beginning to tap big data to speed drug discovery

Companies are beginning to tap big data to speed drug discovery
By Peter Winter
BioWorld Insight Editor
Biotechnology is no stranger to the creation and analysis of large amounts of data, whether it is “-omics” in nature or from patients Read More

press
Published on: May 16, 2017 | BRANFORD, CT.

InveniAI® Is Launched with Industry-leading Artificial Intelligence (AI) Powered R&D Engine for Biotech and Pharma Partners

InveniAI® is launched by BioXcel Corp. to accelerate innovation and commercial growth of proprietary AI platforms, EvolverAI and PharmGPS®
BRANFORD, CT., May 16, 2017 – BioXcel Corporation, a privately held biopharmaceutical company pioneering the integration of big data analytics and Read More

press
Published on: May 24, 2016 | BRANFORD, CT.

BioXcel Begins Strategic Collaboration with Alnylam to Discover Novel RNAi Therapeutic Products

Partnership to Harness the Power of BioXcel’s Big Data Innovation Lab
BRANFORD, Conn., May 24, 2016 (GLOBE NEWSWIRE) — BioXcel Corporation, a global leader in real-time big data platforms for the discovery and development of transformative patient treatments, today announced Read More